UBS Group’s Scilex Holding Co Warrant SCLXW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-166
Closed -$16 11085
2025
Q4
$16 Buy
+166
New +$30 ﹤0.01% 10366
2024
Q3
Sell
-5,012
Closed -$2.25K 9994
2024
Q2
$2.25K Buy
5,012
+4,894
+4,147% +$1.53K ﹤0.01% 8395
2024
Q1
$43 Buy
+118
New +$49 ﹤0.01% 8946
2023
Q3
Sell
-1,273
Closed -$1.77K 9900
2023
Q2
$1.77K Buy
+1,273
New +$2.36K ﹤0.01% 7857
2022
Q4
Sell
-55
Closed 11087
2022
Q3
$0 Sell
55
-1,922
-97% -$362 ﹤0.01% 10848
2022
Q2
$0 Buy
+1,977
New +$511 ﹤0.01% 10859
2021
Q3
Sell
-1,944
Closed -$1K 10010
2021
Q2
$1K Buy
1,944
+1,671
+612% +$827 ﹤0.01% 9185
2021
Q1
$0 Buy
+273
New +$146 ﹤0.01% 9407

Other funds holding SCLXW

UBS Group's SCLXW Position: Q1 2026 in Review

UBS Group sold out of Scilex Holding Co Warrant (SCLXW) in Q1 2026, closing a stake of 166 shares — an estimated $16 sold.

UBS Group first reported a position in SCLXW in Q1 2021 and held it in 8 quarters. The position peaked at $2.25K in Q2 2024. 4 funds tracked by Wall St. Rank hold SCLXW as of Q1 2026.

  • UBS Group reported no remaining Scilex Holding Co Warrant position as of Q1 2026 after selling out during the quarter.
  • UBS Group sold 166 Scilex Holding Co Warrant shares in Q1 2026, an estimated $16.
  • UBS Group first reported a position in Scilex Holding Co Warrant in Q1 2021 and held it in 8 quarters.
  • UBS Group's Scilex Holding Co Warrant position peaked at $2.25K in Q2 2024.
  • 4 funds tracked by Wall St. Rank held Scilex Holding Co Warrant as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.